Mark Ratain
UChicago Medicine Faculty Physicians · University of Chicago Medical Center
Credentials: · · · · ·
History
Research
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
New England Journal of Medicine · 2010 · 3,649 citations
Tumour heterogeneity in the clinic
Nature · 2013 · 914 citations
Journal of Clinical Oncology · 2006 · First of 16 authors · Corresponding · 821 citations
64 papers
- NV
62 papers
51 papers
46 papers · 1 as a fellow
41 papers
34 papers
- MM
31 papers
- HG
30 papers
Grants
- 1978–2030
National Institute of General Medical Sciences · T32
Contact PI · $9.4M · University of Chicago
- 1997–2024
National Cancer Institute · P30
Project lead · $1.8M · University of Chicago
- 2014–2019
Experimental Therapeutics: Clinical Trials Network with Phase I Emphasis
National Cancer Institute · UM1
Contact PI · $986.5K · University of Chicago
- 2000–2016
PAAR-Pharmacogenomics of Anticancer Agents Research Group
National Institute of General Medical Sciences · U01
Contact PI · $39M · University of Chicago
Clinical trials
- 2022–2027
Principal investigator · Recruiting
University of Chicago
- 2020–2026
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Principal investigator · Recruiting · Phase 1
University of Chicago
- 2009–2011
Principal investigator · Completed · Phase 1
PharmaMar
- 2005–2011
A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors
Principal investigator · Terminated · Phase 1
PharmaMar